Harmonizing antimicrobial susceptibility testing: a comparison of CLSI and EUCAST categorizations
Journal of Antimicrobial Chemotherapy · 05.05.2026 · 81 (6)
DOI: 10.1093/jac/dkag081 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 29.05.2026. Verfasst von Eric Farfour und 1 weiteren Autor:innen. Beteiligte Einrichtung: www.clin92.com, Rueil-Malmaison, France. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- www.clin92.com, Rueil-Malmaison, France.
- Service de Biologie Clinique, Hôpital Foch, Suresnes, France.
- Service de Biologie Clinique, Institut Médico-Chirurgical Montsouris, Paris, France.
Zitieren
APA
Farfour, E., & Lavollay, M. (2026). Harmonizing antimicrobial susceptibility testing: a comparison of CLSI and EUCAST categorizations. Journal of Antimicrobial Chemotherapy, 81(6). https://doi.org/10.1093/jac/dkag081
Vancouver
Farfour E, Lavollay M. Harmonizing antimicrobial susceptibility testing: a comparison of CLSI and EUCAST categorizations. Journal of Antimicrobial Chemotherapy. 2026;81(6). doi:10.1093/jac/dkag081
BibTeX
@article{Farfour2026,
author = {Farfour, Eric and Lavollay, Marie},
title = {Harmonizing antimicrobial susceptibility testing: a comparison of CLSI and EUCAST categorizations},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2026},
volume = {81},
number = {6},
doi = {10.1093/jac/dkag081}
}
EUVIMED